Lipid system and methods of use

Details Lipid system and methods of use Lipid system and methods of use

2007-10-25

2009-10-13

Carr, Deborah D (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

Reexamination Certificate

active

07601757

ABSTRACT:
The present invention relates to a lipid system, and methods for using such a lipid system, containing specific relative ratios of omega-3, omega-6, and omega-9 fatty acids. The lipid system may be used independently or as a component of a nutritional product. A lipid system according to the present invention may contain omega-3 fatty acids, omega-6 fatty acids, and omega-9 fatty acids with the ratio of omegas-6 fatty acids to omega-3 fatty acids preferably being between 0.25:1 and 3:1, and the ratio of omega-9 fatty acids to omega-3 fatty acids preferably being between 0.4:1 and 3:1. The present invention also relates to methods for administering a lipid system or a nutritional product containing the lipid system to an individual.

REFERENCES:
patent: 4526902 (1985-07-01), Rubin
patent: 4921877 (1990-05-01), Cashmere et al.
patent: 5059622 (1991-10-01), Sears
patent: 5308832 (1994-05-01), Garleb et al.
patent: 5502077 (1996-03-01), Breivik et al.
patent: 5656667 (1997-08-01), Breivik et al.
patent: 5698594 (1997-12-01), Breivik et al.
patent: 5763484 (1998-06-01), Horrobin
patent: 5780451 (1998-07-01), DeMichele et al.
patent: 5895652 (1999-04-01), Giampapa
patent: 5922345 (1999-07-01), Horrobin et al.
patent: 5922704 (1999-07-01), Bland
patent: 5952314 (1999-09-01), DeMichele et al.
patent: 6140304 (2000-10-01), Sears
patent: 6468987 (2002-10-01), DeMichele et al.
patent: 2004/0062847 (2004-04-01), Koike et al.
patent: 1339262 (2002-03-01), None
patent: 0937408 (1993-08-01), None
patent: 0682879 (1995-11-01), None
patent: 1269859 (2003-01-01), None
patent: 2223943 (1990-03-01), None
patent: 8198749 (1996-08-01), None
patent: WO9526646 (1995-10-01), None
patent: WO99/62359 (1999-12-01), None
patent: WO0012179 (2001-02-01), None
patent: WO0211552 (2002-02-01), None
patent: WO0217903 (2003-03-01), None
Kato et al.,Effect of Alpha-Linolenic Acid on Blood Glucose, Insulin and GLUT4 Protein Content of Type 2 Diabetic Mice, Journal of Health Science46, 489-492 (2000).
Hun et al.,Increased Uncoupling Protein2mRNA in White Adepose Tissue, and Decrease in Leptin, Visceral Fat, Blood Glucose, and Cholesterol in KK-AγMice Fed with Eicosapentaenoic and Docosahexaenoic Acids in Addition to Linolenic Acid, Biochemical and Biophysical Research Communications259, 85-90 (1999).
McManus et al.,A Comparison of the Effects of n-3 Fatty Acids from Linseed Oil and Fish Oil in Well-Controlled Type II Diabetes, Diabetes Care19, 463-467 (1996).
Goh et al.,Effect of ω3 Fatty Acid on Plasma Lipids, Cholesterol and Lipoprotein Fatty Acid Content in NIDDM Patients, Diabetologia40, 45-52 (1997).
Nestel, et al.,Aterial Compliance in Obese Subjects in Improved with Dietary Plant n-3 Fatty Acid from Flaxseed Oil Despite Increased LDL Oxidizability, Arteriosclerosis, Thrombosis and Vascular Biology17, 1163-1170 (1996).
Simopoulos,Essential Fatty Acids in Health and Chronic Disease, Am. J. Clin. Nutr. 70 (suppl.), 560S-569S (1999).
Siguel,Deficiencies and Abnormalities and Essential Fats in Gastrointestinal and Coronary Artery Disease, J. Clin. Ligand Assay23, 104-111 (2000).

Affiliated with

Also associated with

Rating

Lipid system and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipid system and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid system and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4076758